M. Zelazko

发表

Characterization of Immunodeficiency in a Patient With Growth Hormone Insensitivity Secondary to a Novel STAT5b Gene Mutation

A. Belgorosky, M. Rivarola, A. Bernasconi, 2006, Pediatrics.

561del4 defines a novel small deletion hotspot in the interferon-γ receptor 1 chain

S. Dorman, S. Rosenzweig, J. Roesler, 2002 .

Immunological Characteristics and Two Novel Mutations in TACI in a Cohort of 28 Pediatric Patients with Common Variable Immunodeficiency

A. Bernasconi, M. Oleastro, M. Zelazko, 2011, Journal of Clinical Immunology.

Etanercept in systemic juvenile idiopathic arthritis.

M. Zelazko, R. Russo, M. Katsicas, 2002, Clinical and experimental rheumatology.

Successful treatment of autoimmune hemolytic anemia with rituximab in a child with severe combined immunodeficiency following nonidentical T-cell-depleted bone marrow transplantation

M. Bonduel, M. Zelazko, A. D. Pozo, 2005, Bone Marrow Transplantation.

Quantification of Epstein-Barr virus load in Argentinean transplant recipients using real-time PCR.

M. Zelazko, M. Cuarterolo, J. Yancoski, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA‐DRB1*1301, a marker for pediatric autoimmune hepatitis

M. Zelazko, L. Fainboim, M. Ciocca, 2001, Hepatology.

Phenotypic analysis of human BM T-cell depleted by soybean lectin agglutination and E rosetting with sheep RBC: relative enrichment of NK cells and a CD3(+),CD2(-dim) population.

M. Bonduel, M. Oleastro, M. Zelazko, 2003, Cytotherapy.

Naturally occurring mutation affecting the MyD88‐binding site of TNFRSF13B impairs triggering of class switch recombination

C. Cunningham-Rundles, P. Oppezzo, M. Cols, 2013, European journal of immunology.

561del4 defines a novel small deletion hotspot in the interferon-gamma receptor 1 chain.

S. Dorman, S. Holland, S. Rosenzweig, 2002, Clinical immunology.

Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease.

S. Holland, S. Rosenzweig, Y. Shea, 2006, Medical mycology.

X-Linked Chronic Granulomatous Disease: First Report of Mutations in Patients of Argentina

R. Zandomeni, S. Copelli, M. Oleastro, 2004, Journal of pediatric hematology/oncology.

M. Bonduel, M. Zelazko, A. D. Pozo, 1999, Bone Marrow Transplantation.

Clinical and histopathological features and a unique spectrum of organisms significantly associated with chronic granulomatous disease osteomyelitis during childhood.

S. Rosenzweig, M. Oleastro, M. Zelazko, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunological Characteristics and Two Novel Mutations in TACI in a Cohort of 28 Pediatric Patients with Common Variable Immunodeficiency

A. Bernasconi, M. Oleastro, M. Zelazko, 2012, Journal of Clinical Immunology.

Serum Levels of Interleukin-1 Receptor Antagonist and Tumor Necrosis Factor-Alpha Are Elevated in Children With Langerhans Cell Histiocytosis

M. Zelazko, R. Diez, J. Braier, 2003, Journal of pediatric hematology/oncology.

Noninfectious complications in patients with pediatric‐onset common variable immunodeficiency correlated with defects in somatic hypermutation but not in class‐switch recombination

P. Oppezzo, M. Oleastro, M. Zelazko, 2017, The Journal of allergy and clinical immunology.

Prognostic value of soluble interleukin 2 receptor levels in Langerhans cell histiocytosis

M. Zelazko, J. Braier, D. Rosso, 2002, British journal of haematology.

Primary Immunodeficiency Diseases in Latin America: First Report from Eight Countries Participating in the LAGID

R. Sorensen, M. Zelazko, M. Carneiro-Sampaio, 1998, Journal of Clinical Immunology.

Clinical Follow-Up of 11 Argentinian CD40L-Deficient Patients with 7 Unique Mutations Including the So-Called “Milder” Mutants

M. Oleastro, M. Zelazko, S. Danielián, 2007, Journal of Clinical Immunology.

Clinical and Molecular Analysis of 49 Patients With X-linked Agammaglobulinemia From A Single Center in Argentina

S. Rosenzweig, J. Rossi, M. Oleastro, 2008, Journal of Clinical Immunology.

Wiskott‐Aldrich syndrome in Argentina: 17 unique, including nine novel, mutations

S. Rosenzweig, M. Oleastro, M. Zelazko, 2002, Human mutation.

Novel Syntaxin 11 Gene (STX11) Mutation in Three Argentinean Patients with Hemophagocytic Lymphohistiocytosis

P. Roche, A. Bernasconi, J. Rossi, 2010, Journal of Clinical Immunology.

Bruton tyrosine kinase gene mutations in Argentina

S. Rosenzweig, M. Oleastro, M. Zelazko, 2003, Human mutation.

Cholestasis in juvenile dermatomyositis: report of three cases.

M. Zelazko, M. Ciocca, R. Russo, 2001, Arthritis and rheumatism.

[Registry of the primary immunodeficiencies].

M. Zelazko, M. E. Rivas, A. Malbrán, 1994, Medicina.

Beta 2-adrenergic polymorphisms and total serum IgE levels in children with asthma from Argentina.

M. Zelazko, V. Giubergia, L. Gravina, 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Efficacy and Tolerability of an Argentine Intravenous Immunoglobulin in Pediatric Patients with Primary Immunodeficiency Diseases

S. Rosenzweig, M. Oleastro, A. Ornani, 2007, Journal of Clinical Immunology.

Genetic, molecular and functional analyses of complement factor I deficiency

A. Blom, L. Trouw, L. Truedsson, 2009, European journal of immunology.

Pulmonary fungal infection diagnosis in chronic granulomatous disease patients

S. Rosenzweig, M. Oleastro, M. Zelazko, 2007, Pediatric Pulmonology.

Letter: Behavior of the complement system in the nephropathy of congenital syphilis.

M. Zelazko, G. Feldman, 1976, The Journal of pediatrics.